- Alcidion’s reseller agreement with NextGate now expanded to include United Kingdom and Ireland.
- Expansion strengthens competitive position in UK market as NHS transitions to digitised healthcare solutions and integrated care records.
Alcidion Group Limited (ASX:ALC) is pleased to announce an expansion of its reseller agreement with NextGate to the United Kingdom and Ireland.
In 2018, MKM Health (which was acquired by Alcidion in 2018) signed an agreement to resell NextGate’s market leading Enterprise Master Patient Index (EMPI) and Provider Registry solutions in Australia and New Zealand. Following a successful two-year relationship, this agreement has now been extended to also include the United Kingdom and Ireland.
NextGate is the global leader in healthcare enterprise identification, helping healthcare organisations overcome the clinical, operational and financial challenges that result from duplicate records and disparate data.
Alcidion’s reseller agreement with NextGate has already realised success with two significant state-wide contracts in Australia. The Queensland Health Referral Service Directory based on the Provider Index was delivered by Alcidion working closely with NextGate. For the Victorian Department of Health and Human Services Unique Patient Identification program, Alcidion supported NextGate in delivery of their EMPI capability.
The expansion of the agreement to the United Kingdom and Ireland will contribute to the Company’s growth strategy by reinforcing its competitive position in the UK market and enabling it to complement its flagship Miya Precision product suite with the NextGate solution.
Lynette Ousby, UK General Manager of Alcidion, said: “With the current focus in the NHS on consolidating clinical systems across regions, the ability to include the offering of NextGate solutions to complement our Miya Precision capability, establishes a true enterprise approach to healthcare delivery.”
Alcidion’s Miya Precision presents the NHS with an opportunity to consolidate disparate systems using modern technology based on the FHIR standard, and establish smart clinical engagement supported by tailored clinical decision support. The inclusion of the NextGate Patient and Provider Registries, which are built on the MatchMetrix® master identity platform, will extend that capability to effectively manage identity for both patients and healthcare providers.
“We are delighted to expand our partnership with Alcidion to facilitate a modernised NHS infrastructure where patients are accurately identified and consistently matched to their health and social care data,” said Andy Aroditis, CEO of NextGate. “Together, Alcidion and NextGate are delivering innovative interoperable solutions that maximise the quality, efficiency and coordination of care.”
Alcidion Managing Director, Kate Quirke commented: “I am delighted that we can now expand our success implementing the NextGate solution in Australia to the UK. The combination of our service delivery and domain expertise with the powerful capabilities of MatchMetrix creates a compelling opportunity for the health sector to establish first class identity management.”